Best Hodgkin's lymphoma hematologist-oncologists: TOP 80 doctors

• Prof. MD Zafer Gulbas specializes in the treatment of Hodgkin's lymphoma, focusing on advanced .
• He utilizes chemotherapy, radiation therapy, immunotherapy, targeted therapy, and transplants.
• Prof. Gulbas has received international training at medical institutions in Israel, the USA (Seattle, Houston), and Canada.
• He is the founder of the Center at Anadolu Medical Center.
• He is a member of the American Society of Hematology and the European Hematology Association.

• Dr. Bülent Karagöz specializes in Hodgkin's lymphoma treatment using chemotherapy, radiation therapy, immunotherapy, and targeted therapies.
• Dr. Bülent Karagöz has experience of international practice at NATO KFOR Command and Turkish Cypriot Peace Forces Command.
• Medical oncologist at Anadolu Medical Center since 2019.
• Member of the Turkish Medical Oncology Association.
• Over 40 publications in cancer research, emphasizing tumor biology and immunology.

• Dr. Yesim Yildirim specializes in Hodgkin's lymphoma treatment using chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
• Dr. Yesim Yildirim has experience practicing at medical institutions in the United States, Turkey, Israel, and the United Kingdom.
• Certified by the European Society of Medical Oncology (ESMO) and a member of the European School of Oncology (ESO).
• Currently a Professor at Anadolu Medical Centre and Haliç University, Istanbul, Turkey.
• Languages spoken: English, Russian (B1 level), Turkish.

Professor Fabio Ciceri is the Head of the Hematology and Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Eduardo Fernandez, MD

Medical Doctor & Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in therapies and regenerative medicine. He is a certified member of the Mexican College of and Regenerative Medicine, as well as the Mexican Council of for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

• Head physician of Oncology and Hematology Center, specializing in Hodgkin's lymphoma treatment.
• Over 35 years of practice in oncology and hematology.
• Uses chemotherapy, radiation therapy, immunotherapy, and transplantation for Hodgkin's lymphoma.
• Has experience of international practice at medical institutions in Germany, the USA, and Switzerland.
• Recognized as one of the best German oncologists by Focus rating.

Areas of Interest

2. Leukemia
3. Lymphoma
4. Multiple myeloma
5. Thalassemia
6. diseases
7. pheresis

Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist

Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department

Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis

Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain

Courses, Awards, and Certificates
1 Year of Work Certificate in , 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005

Research and Publications

Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.

Scientific Studies
A. Publications in International Journals under SCI Expanded


 Turkish book section

1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.

2. Özen M, Ural AU. Hematological diseases and mesenchymal applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.

3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (E)
• Hematologic Oncology Association
• Antalya Medical Chamber

Head of the Hematology, Oncology and Department

• Expert in Hodgkin's lymphoma treatment, specializing in chemotherapy, radiation therapy, and transplantation.
• The doctor has experience of international practice at medical institutions in Spain, the United States, and the United Kingdom.
• Member of the European Hematology Association, promoting excellence in patient care and research.
• Fluent in Spanish and English, adept at communicating with patients from various backgrounds.
• Renowned for her expertise in pediatric hematology and .

• Dr. Eckhart Weidemann specializes in the treatment of Hodgkin's lymphoma with over 30 years of experience.
• He leads the Hematology sector at Nordwest Clinic, focusing on treatments for blood disorders.
• Standard treatment options for Hodgkin's lymphoma include chemotherapy, radiation therapy, immunotherapy, and transplant.
• Dr. Weidemann has experience practicing at medical institutions in Germany, the USA, and the UK.
• Professional memberships: American Society of Hematology, European Hematology Association.

Education and Expertise

• EGE UNIVERSITY FACULTY OF MEDICINE

Diseases

• Acute Leukemias
• Aplastic Anemia
• Other Hematological Cancers
• Hodgkin lymphoma
• Chronic Lymphocytes Leukemia
• Chronic myelogenous leukemia
• Multiple myeloma
• Non-Hodgkin lymphoma

Treatment Methods

• Apheresis Application
• Cell Transplantation
• Photopheresis application
• Haploidentical
• Targeted Therapies
• Immunotherapy
• Chemoimmunotherapy
• Cell Transplantation
• pheresis

Experience

• Ege University Faculty of Medicine – Department of Internal Medicine – Specialization
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Assistant Professorship
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Associate Professorship
• Ege University Faculty of Medicine – Department of Internal Medicine – Hematology – Professor

Professional Memberships

• Turkish Medical Association
•  

Experience

2021 year - 2022 year

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 year - 2022 year

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 year - 2021 year

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 year - 2020 year

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 year - 2017 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 year - 2016 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 year - 2011 year

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 year - 2010 year

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006 year

Medical Faculty, Dokuz Eylül University

2006 year - 2008 year

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 year - 2006 year

Medical Faculty, Dokuz Eylül University

Education

2022 year

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022 year

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021 year

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017 year

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017 year

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006 year

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006 year

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998 year

Ege University, Faculty of Medicine

Kodchanut Litleaungdej, M.D.

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology " Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology " Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for "Online" Data Registry Sy 2007-ongoing.
• Ege University Regenerative Medicine and Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for (E); Ege University Pediatric Unit was accredited by the European Group for (E) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Unit (1992) 
3- EU Faculty of Medicine Pediatric Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Unit (2019) 
2. Ümraniye EAH Pediatric Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric transplantation activity- Oral presentation second prize, Turkish Hematology Society Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. " and Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Journal of Turkish Clinics. 2003

Kansoy S. Cell Applications in and Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Cell Source. Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous Sy Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric transplant activity, 2020

Childhood transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Professor of Oncology and Hematology